WAM
MRTX

Wealthspire Advisors (Maryland)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,300
Closed -$95K – 2240
2019
Q1 		$95K Buy
+1,300
New +$95K 0.01% 657